Vaccines status as of today

  • Moderna: Expecting data in late November 2020
  • Pfizer: Also expecting data in late November 2020
  • AstraZeneca: Began Phase III on August 31, paused due to adverse events on September 9, resumed October 23, 2020
  • Johnson & Johnson: Started Phase III on September 23, paused due to adverse events on October 12, re-started October 23, 2020